To determine the clinical efficacy of surgery followed by local brain radiotherapy (LBRT) for patients with a single brain metastasis, by comparing the results with those of postoperative whole brain radiotherapy (WBRT).
Methods
We performed a retrospective analysis to compare the survival rate, recurrence-free rates, and causes of death for single brain metastasis patients who underwent surgery followed by LBRT or WBRT in the 2010-2015 period.
Results
After their surgery, 22 and 32 patients were treated by LBRT and WBRT, respectively. The median survival times for these LBRT and WBRT groups were 18.3 months and 19.2 months, respectively (p = 0.356). The local recurrence-free rates were 81.2% at 1 year and 81.2% at 2 years after LBRT, and 63.8% at 1 year and 58.9% at 2 years after WBRT (p = 0.589). The distant brain recurrence-free rates were 42.5% at 1 year and 25.5% at 2 years after LBRT, and 69.8% at 1 year and 52.4% at 2 years after WBRT (p = 0.044). Distant brain recurrences were observed significantly more frequently in the LBRT group, but the rates of salvage treatment application and survival were not significantly different between the LBRT and WBRT groups. The probability of neurologic death was not significantly higher in the LBRT group compared with the WBRT group.
Conclusions
Surgery followed by LBRT for single brain metastasis is not inferior to postoperative WBRT, because survival and the necessity of salvage treatment after LBRT were equivalent to those after WBRT.
AmsbaughM., PanJ., YusufM.B.Dose-volume response relationship for brain metastases treated with frameless single-fraction linear accelerator-based stereotactic radiosurgery. Cureus.2016; 8(4): e587.
3.
WiggenraadR., Verbeek-de KanterA., KalH.B., TaphoornM., VissersT., StruikmansH.Dose-effect relation in stereotactic radiotherapy for brain metastases. A systematic review. Radiother Oncol.2011; 98(3): 292–297.
4.
PatchellR.A., TibbsP.A., RegineW.F.Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA.1998; 280(17): 1485–1489.
5.
BrownP.D., JaeckleK., BallmanK.V.Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: A randomized clinical trial. JAMA.2016; 316(4): 401–409.
6.
ChangE.L., WefelJ.S., HessK.R.Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol.2009; 10(11): 1037–1044.
7.
GondiV., PughS.L., TomeW.A.Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. J Clin Oncol.2014; 32(34): 3810–3816.
8.
YamamotoM., SerizawaT., ShutoT.Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol.2014; 15(4): 387–395.
HashimotoK., NaritaY., MiyakitaY.Comparison of clinical outcomes of surgery followed by local brain radiotherapy and surgery followed by whole brain radiotherapy in patients with single brain metastasis: single-center retrospective analysis. Int J Radiat Oncol Biol Phys.2011; 81(4): e475–e480.
11.
AritaH., NaritaY., MiyakitaY., OhnoM., SumiM., ShibuiS.Risk factors for early death after surgery in patients with brain metastases: reevaluation of the indications for and role of surgery. J Neurooncol.2014; 116(1): 145–152.
12.
Randomized phase III trial of postoperative whole brain radiation therapy compared with salvage stereotactic radiosurgery in patients with one to four brain metastasis: Japan Clinical Oncology Group Study (JCOG 0504) [https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000389]. Accessed Mar 8, 2017.
13.
SperdutoP.W., KasedN., RobergeD.Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol.2012; 30(4): 419–425.
14.
CouckeP.A., ZouhairA., OzsahinM., De TriboletN., MirimanoffR.O.Focalized external radiotherapy for resected solitary brain metastasis: does the dogma stand?Radiother Oncol.1998; 47(1): 99–101.
15.
AoyamaH., ShiratoH., TagoM.Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA.2006; 295(21): 2483–2491.
16.
KocherM., SoffiettiR., AbaciogluU.Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 2295226001 study. J Clin Oncol.2011; 29(2): 134–141.
17.
KayamaT., SatoS., SakuradaK.JCOG0504: A phase iii randomized trial of surgery with whole brain radiation therapy versus surgery with salvage stereotactic radiosurgery in patients with 1 to 4 brain metastases. 2016 ASCO Annual Meeting. 2016Abstract #2003.
18.
PatelK.R., PrabhuR.S., KandulaS.Intracranial control and radiographic changes with adjuvant radiation therapy for resected brain metastases: whole brain radiotherapy versus stereotactic radiosurgery alone. J Neurooncol.2014; 120(3): 657–663.
19.
HsiehJ., ElsonP., OtvosB.Tumor progression in patients receiving adjuvant whole-brain radiotherapy vs localized radiotherapy after surgical resection of brain metastases. Neurosurgery.2015; 76(4): 411–420.
20.
MahajanA., AhmedS., LiJ.Postoperative stereotactic radiosurgery versus observation for completely resected brain metastases: Results of a prospective randomized study. International Journal of Radiation Oncology • Biology • Physics.2016; 96(2): S2.
21.
PessinaF., NavarriaP., CozziL.Outcome evaluation of oligometastatic patients treated with surgical resection followed by hypofractionated stereotactic radiosurgery (hsrs) on the tumor bed, for single, large brain metastases. PLoS ONE.2016; 11(6): e0157869.
22.
PessinaF., NavarriaP., CozziL.Role of surgical resection in patients with single large brain metastases: Feasibility, morbidity, and local control evaluation. World Neurosurg.2016; 94: 6–12.
23.
AtalarB., ChoiC.Y., HarshGRIVCavity volume dynamics after resection of brain metastases and timing of postresection cavity stereotactic radiosurgery. Neurosurgery.2013; 72(2): 180–185, discussion 185.
24.
JarvisL.A., SimmonsN.E., BelleriveM.Tumor bed dynamics after surgical resection of brain metastases: implications for postoperative radiosurgery. Int J Radiat Oncol Biol Phys.2012; 84(4): 943–948.
25.
GasparL., ScottC., RotmanM.Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys.1997; 37(4): 745–751.
26.
LiJ., BentzenS.M., RenschlerM., MehtaM.P.Regression after whole-brain radiation therapy for brain metastases correlates with survival and improved neurocognitive function. J Clin Oncol.2007; 25(10): 1260–1266.
